The latest prices for a box of different versions of evantumumab are announced

Introduction: Evantumumab, trade name Rybrevant, is a targeted drug used to treat specific types of non-small cell lung cancer. Evantumumab induces degradation of both receptors in vivo, broadening their mechanisms of action to include ligand-independent driving of disease, resulting in the prevention of downstream signaling by pro-growth and pro-survival proteins. Evantumumab simultaneously inhibits EGFR and one of the most common mechanisms of resistance to EGFR-targeted therapies through the MET pathway. This combined inhibition has the potential to enhance the depth and duration of responses in patients with these mutations.

What are the different versions of evantuzumab?

Currently there is only the original drug, but it may be called other versions when exported to other countries or regions. For example, the evantuzumab exported to Turkey can be called the exported Turkish version, and the exported to Hong Kong, China, can be called the exported Hong Kong version. In fact, they are all original drugs produced by Janssen Pharmaceuticals in the United States.

Prices of different versions of evantumumab

The specification of a box of evantumumab is 350mg/7ml. The price currently known is about 10,300$-10,900$ per box, which is relatively expensive. The price of evantumumab may have changed and may not reflect current market prices or actual selling prices in a particular region. Patients should consult their doctor or pharmacist for accurate cost information and drug version details when considering medication.

Where to buy evantumumab

1. Medical institutions: evantumumab can be purchased through pharmacies in hospitals or clinics. It is provided to patients after being prescribed by a doctor. It can be purchased at hospitals or clinics in countries or regions where evantumumab has been marketed.

2. Retail pharmacies: In some listed countries, patients can purchase evantumumab in pharmacies, but they must have a doctor's prescription.

3. Drug manufacturers: The drug manufacturer of evantumumab may sell the drug directly to patients or other medical institutions.

4. Going abroad: In some cases, patients may consider going abroad to purchase evantumumab from other countries.

Side effects of evantumumab

The most common side effects of evantumumab include rash, infusion-related reactions, skin infection around the nails, muscle and joint pain, shortness of breath, nausea, feeling very tired, swelling of the hands, ankles, feet, face, or body, mouth sores, cough, constipation, vomiting, and changes in certain blood tests, such as decreased albumin levels, increased blood sugar levels, and elevated liver enzymes. Evantumumab can cause serious side effects, including infusion-related reactions, lung inflammation, skin problems, eye problems, and harm to your unborn baby.